Spot on mate. Based on Recce's current pace in trials and clear shift to gain an income stream from eastern countries in order to minimise dilution, I can't see us seeing a RCE drug in westen markets this decade. Any work in this space is more or less for long term, or just to keep the employees (family) busy to justify their exorbitant wages.
- Forums
- ASX - By Stock
- RCE
- Ann: Approval to Start Phase I/II Diabetic Foot Ulcer Study
RCE
recce pharmaceuticals ltd
Add to My Watchlist
7.14%
!
39.0¢

Ann: Approval to Start Phase I/II Diabetic Foot Ulcer Study, page-16
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
39.0¢ |
Change
-0.030(7.14%) |
Mkt cap ! $112.7M |
Open | High | Low | Value | Volume |
40.0¢ | 42.0¢ | 37.0¢ | $77.62K | 193.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 30531 | 38.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.0¢ | 49884 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 30531 | 0.385 |
1 | 17995 | 0.370 |
2 | 7654 | 0.365 |
3 | 74306 | 0.360 |
1 | 25000 | 0.355 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 49884 | 1 |
0.400 | 21547 | 1 |
0.425 | 10819 | 1 |
0.440 | 8669 | 2 |
0.450 | 20976 | 3 |
Last trade - 16.10pm 29/07/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |